Weber Shandwick's Yoder Moves to Ruder Finn

Why It Matters

The hire bolsters Ruder Finn’s health practice, positioning it to capture growth as AI transforms stakeholder engagement, and intensifies competition among PR firms for lucrative pharma and biotech accounts.

Key Takeaways

• Kelly Yoder joins Ruder Finn as head of health & life sciences
• Over 20 years experience across pharma, biotech, devices, diagnostics
• Will align rf.Digital, rf.Studio53, rf.TechLab for AI‑driven campaigns
• Ruder Finn ranks #6 in O’Dwyer 2026 healthcare, $74.1M fees

Pulse Analysis

The public‑relations landscape for health and life‑sciences firms is undergoing rapid transformation. As artificial intelligence reshapes data analysis, stakeholder mapping and content personalization, agencies must blend traditional storytelling with tech‑enabled insight. Clients in pharmaceuticals, biotech, medical‑devices and diagnostics are demanding faster, more precise communication strategies that can cut through a crowded digital environment. These dynamics also encourage agencies to invest in proprietary analytics tools that can predict media impact in real time.

Kelly Yoder’s appointment as managing director and head of health & life sciences at Ruder Finn reflects that demand. With more than two decades of experience steering communications and product‑marketing programs for global pharma giants and innovative biotech startups, Yoder brings a rare blend of strategic vision and executional depth. Her tenure at Weber Shandwick, where she rose to North America health lead, equipped her with award‑winning campaign credentials and a network of senior industry contacts. By joining Ruder Finn, she is poised to elevate the agency’s health practice to a more data‑driven, AI‑centric model.

Ruder Finn, currently ranked sixth in O’Dwyer’s 2026 healthcare league table with $74.1 million in fee income, is leveraging Yoder’s expertise to accelerate growth. Integrating her leadership across rf.Digital, rf.Studio53 and rf.TechLab will enable the firm to deliver unified, insight‑driven programs that respond to shifting stakeholder behaviors. The move signals intensified competition among PR firms for high‑margin health accounts and underscores the strategic importance of AI‑enabled communication platforms in capturing future market share.